Millie Fox

1PUBLICATIONS
6CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 14, 2022
AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors.

Shanade Dunn, Cath Eberlein, Jason Yu

Pageof 1

Frequent Collaborators

1 joint publications

Albert Gris-Oliver

1 joint publications

Mathew J Garnett

1 joint publications

Violeta Serra

1 joint publications

Barry R Davies